表紙
市場調查報告書
商品編碼
1020678

迅速檢驗市場:現狀分析與預測(2021年∼2027年)

Rapid Tests Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

快速測試可以在訓練有素的醫療保健專業人員的環境中使用,並且可以無創或最低限度地採集樣本,例如從毛細血管中提取血液。有各種快速檢查平台,每個平台都有其優點和局限性。

快速檢測不僅可以用作診斷工具,還可以用作流行病學工具。還可用於確定高劑量藥物是否已成功治療淋巴絲蟲病。症狀學上可識別的疾病減少了對快速檢測的需求,但可以防止過度使用抗生素。

本報告提供全球迅速檢驗市場的相關調查,市場機會和趨勢,成長要素及課題,COVID-19大流行的影響,各產品類型、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 報告所使用的貨幣
  • 迅速檢驗市場調查範圍

第2章 調查手法或前提條件

  • 迅速檢驗市場調查手法

第3章 產業的成果

第4章 摘要整理

第5章 COVID-19的影響

第6章 各產品類型的市場洞察

  • 市售(OTC)迅速檢驗產品
  • 專家用迅速檢驗產品

第7章 各用途的市場洞察

  • 感染疾病
    • HPV
    • 肝炎
    • 流感
    • 瘧疾
    • HIV
    • 其他
  • 心臟病
  • 腫瘤
  • 妊娠與生產
  • 毒物學
  • 葡萄糖監測
  • 其他

第8章 各終端用戶的市場洞察

  • 醫院、診所
  • 診斷研究所
  • 居家護理
  • 其他

第9章 各地區的市場洞察

  • 北美的迅速檢驗市場
    • 美國
    • 加拿大
    • 北美
  • 歐洲的迅速檢驗市場
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的迅速檢驗市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 全球殘餘的迅速檢驗市場

第10章 法律及法律規範

第11章 需求與供給方面分析

  • 需求面分析
  • 供給方面分析
    • 主要產品的銷售
    • 主要事業聯盟
    • 主要事業擴大,投資及出售
    • 主要的合併和收購

第12章 價值鏈分析

第13章 迅速檢驗市場趨勢、洞察

第14章 迅速檢驗市場動態

  • 成長要素
  • 課題
  • 影響分析
  • 市場機會

第15章 競爭模式

  • 到2020年為止的迅速檢驗的市場佔有率

第16章 企業概要

  • ACON Laboratories, Inc.
  • Abbott Laboratories
  • Artron Laboratories Inc.
  • Alfa Scientific Designs, Inc.
  • Becton, Dickinson and Company
  • BTNX, Inc.
  • bioMerieux SA
  • Cardinal Health
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation

第17章 免責聲明

目錄
Product Code: UMHE21298

Rapid tests are parasite-based diagnosis tests in cases where microscopy is not possible. These tests are designed to be used in point-of-care (POC) and are adapted for use in low-resource setting. Rapid tests are low-cost, simple to use, specific, sensitive, stable, and high temperatures. These tests are being used for a variety of diseases.

Rapid Tests can be used in settings with minimally trained healthcare professionals, additionally, the samples can be collected non-invasively or with low invasion such as blood extraction from capillaries. There are a variety of platforms for rapid tests, each with their own benefits and limitations. Mechanism of these tests are usually based on immunoassay technology, where a fixed reagent can react with the target antigen or antibody and is linked to some type of a visible detector which then reacts to the sample of the patient. In addition to their use as diagnostic tools, rapid tests can also be used as epidemiological tools. It enables the rapid screening of a potentially affected population and can be used with lymphatic filariasis to test if a mass drug administration has been successful. Rapid tests are less necessary in diseases that can be syndromically identified, but it can also prevent over prescription of antibiotics.

Based on product type, the rapid tests market is segmented into Over the counter (OTC) Rapid Test Product, and Professional Rapid Test Product. Amongst product type, the professional rapid tests segment of the rapid tests market was valued at US$ XX billion in 2020 and is likely to reach US$ XX billion by 2027.

Based on application, the rapid tests market is segmented into Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others. The infectious disease segment is further fragmented into HPV, Hepatitis, Influenza, Malaria, HIV, and Others. Amongst application, infectious diseases accounted for a market valuation of US$ XX billion in 2020 and is expected to reach US$ XX billion by the year 2027, at a CAGR of XX% over the analyzed period.

Based on end-user, the rapid tests market is segmented into Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others. The hospital & clinic segment generated revenue of US$ XX billion in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of US$ XX billion by 2027F.

For a better understanding of the market adoption of Rapid Tests Industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Rapid Tests market on account of the increasing infectious diseases which are on the rise all over the world.

Some of the major players operating in the market include ACON Laboratories, Inc., Abbott Laboratories, Artron Laboratories Inc., Alfa Scientific Designs, Inc., Becton, Dickinson and Company, BTNX, Inc., bioMerieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., Danaher Corporation. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Objective of the Study
  • 1.3. Limitation
  • 1.4. Stake Holders
  • 1.5. Currency Used in Report
  • 1.6. Scope of the Rapid Tests Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Methodology for the Rapid Tests Market
    • 2.1.1. Main Objective of the Rapid Tests Market

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT TYPE

  • 6.1. Over-the-counter (OTC) Rapid Test Product
  • 6.2. Professional Rapid Test Product

7 MARKET INSIGHTS BY APPLICATION

  • 7.1. Infectious Disease
    • 7.1.1. HPV
    • 7.1.2. Hepatitis
    • 7.1.3. Influenza
    • 7.1.4. Malaria
    • 7.1.5. HIV
    • 7.1.6. Others
  • 7.2. Cardiology
  • 7.3. Oncology
  • 7.4. Pregnancy & Fertility
  • 7.5. Toxicology
  • 7.6. Glucose Monitoring
  • 7.7. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospital & Clinic
  • 8.2. Diagnostic Laboratory
  • 8.3. Home Care
  • 8.4. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. NORTH AMERICA RAPID TESTS MARKET
    • 9.1.1. United States of America
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. EUROPE RAPID TESTS MARKET
    • 9.2.1. United Kingdom
    • 9.2.2. Germany
    • 9.2.3. France
    • 9.2.4. Spain
    • 9.2.5. Italy
    • 9.2.6. Rest of Europe
  • 9.3. ASIA-PACIFIC RAPID TESTS MARKET
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. Rest of Asia-Pacific
  • 9.4. REST OF THE WORLD RAPID TESTS MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

  • 11.1. Demand Side Analysis
  • 11.2. Supply Side Analysis
    • 11.2.1. Top Product Launches
    • 11.2.2. Top Business Partnerships
    • 11.2.3. Top Business Expansions, Investments and Divestitures
    • 11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 RAPID TESTS MARKET TRENDS & INSIGHTS

14 RAPID TESTS MARKET DYNAMICS

  • 14.1. Drivers
  • 14.2. Challenges
  • 14.3. Impact Analysis
  • 14.4. Opportunity

15 COMPETITIVE SCENARIO

  • 15.1. Rapid Tests Market Share, by Company 2020

16 COMPANY PROFILED

  • 16.1. ACON Laboratories, Inc.
  • 16.2. Abbott Laboratories
  • 16.3. Artron Laboratories Inc.
  • 16.4. Alfa Scientific Designs, Inc.
  • 16.5. Becton, Dickinson and Company
  • 16.6. BTNX, Inc.
  • 16.7. bioMerieux SA
  • 16.8. Cardinal Health
  • 16.9. Bio-Rad Laboratories, Inc.
  • 16.10. Danaher Corporation

17 DISCLAIMER